Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar 12;3(3):e001541.
doi: 10.1136/bmjopen-2012-001541.

The clinical implications of elevated blood metal ion concentrations in asymptomatic patients with MoM hip resurfacings: a cohort study

Affiliations

The clinical implications of elevated blood metal ion concentrations in asymptomatic patients with MoM hip resurfacings: a cohort study

David J Langton et al. BMJ Open. .

Erratum in

  • Correction.
    [No authors listed] [No authors listed] BMJ Open. 2013 May 9;3(5):e001541corr1. doi: 10.1136/bmjopen-2012-001541corr1. BMJ Open. 2013. PMID: 23667157 Free PMC article. No abstract available.

Abstract

Objective: To determine whether elevated blood cobalt (Co) concentrations are associated with early failure of metal-on-metal (MoM) hip resurfacings secondary to adverse reaction to metal debris (ARMD).

Design: Cohort study.

Setting: Single centre orthopaedic unit.

Participants: Following the identification of complications potentially related to metal wear debris, a blood metal ion screening programme was instigated at our unit in 2007 for all patients with Articular Surface Replacement (ASR) and Birmingham MoM hip resurfacings. Patients were followed annually unless symptoms presented earlier. Symptomatic patients were investigated with ultrasound scan and joint aspiration. The clinical course of all 278 patients with 'no pain' or 'slight/occasional' pain and a Harris Hip Score greater than or equal to 95 at the time of venesection were documented. A retrospective analysis was subsequently conducted using mixed effect modelling to investigate the temporal pattern of blood Co levels in the patients and survival analysis to investigate the potential role of case demographics and blood Co levels as risk factors for subsequent failure secondary to ARMD.

Results: Blood Co concentration was a positive and significant risk factor (z=8.44, p=2×10(-16)) for joint failure, as was the device, where the Birmingham Hip Resurfacing posed a significantly reduced risk for revision by 89% (z=-3.445, p=0.00005 (95% CI on risk 62 to 97)). Analysis using Cox-proportional hazards models indicated that men had a 66% lower risk of joint failure than women (z=-2.29419, p=0.0218, (95% CI on risk reduction 23 to 89)).

Conclusions: The results suggest that elevated blood metal ion concentrations are associated with early failure of MoM devices secondary to adverse reactions to metal debris. Co concentrations greater than 20 µg/l are frequently associated with metal staining of tissues and the development of osteolysis. Development of soft tissue damage appears to be more complex with females and patients with ASR devices seemingly more at risk when exposed to equivalent doses of metal debris.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Violin plot showing distribution blood cobalt concentrations in men and women.
Figure 2
Figure 2
Predicted survival curves for hip replacements for two male and two female hypothetical individuals with different levels of blood cobalt at 2 and 5 µg/l. Device is the Birmingham Hip Resurfacing. Time period is in months. Survival curves shown with 95% CI.
Figure 3
Figure 3
Predicted survival curves for hip replacements for two male and two female hypothetical individuals with different levels of blood cobalt of 2 and 5 µg/l. Device is the Articular Surface Replacement. Time period is in months. Survival curves shown with 95% CI.
Figure 4
Figure 4
Predicted survival curves for hip replacements for two male and two female hypothetical individuals with blood cobalt concentrations of 10 µg/l. Device is the Birmingham Hip Resurfacing (top two plots) and Articular Surface Replacement (bottom two plots). Time period is in months. Survival curves shown with 95% CI.
Figure 5
Figure 5
The incidence of osteolysis and/or moderate/severe soft tissue destruction at revision surgery. Patients have been grouped according to their preoperative blood result.
Figure 6
Figure 6
Operative findings of a 55-year-old patient from another country. He had minimal discomfort but was not satisfied with his surgeon's opinion that ‘there was nothing to be concerned about’. His preoperative blood cobalt concentration was 217 µg/l. Note the gross metal staining of the tissues (metallosis) and abnormal fluid. There was extensive acetabular and femoral osteolysis.
Figure 7
Figure 7
The femoral neck and prosthesis of a male patient in this study with a Birmingham Hip Resurfacing who was found to have blood cobalt of 155 µg/l on routine screening. He had no symptoms but elected for surgery 2 years later when he developed progressive discomfort in his hip. There were no obvious changes on plain x-rays. As can be seen on the right, there was a large cavity in the femoral neck filled with metal-stained, caseous material.

References

    1. McMinn D, Treacy R, Lin K, et al. Metal on metal surface replacement of the hip. Experience of the McMinn prothesis. Clin Orthop Relat Res 1996;89–98 - PubMed
    1. Treacy RB, McBryde CW, Shears E, et al. Birmingham hip resurfacing: a minimum follow-up of ten years. J Bone Joint Surg (Br) 2011;93:27–33 - PubMed
    1. Coulter G, Young DA, Dalziel RE, et al. Birmingham hip resurfacing at a mean of ten years: results from an independent centre. J Bone Joint Surg (Br) 2012;94:315–21 - PubMed
    1. Delaunay C, Petit I, Learmonth ID, et al. Metal-on-metal bearings total hip arthroplasty: the cobalt and chromium ions release concern. Orthop Traumatol Surg Res 2010;96:894–904 - PubMed
    1. Jones DA, Lucas HK, O'Driscoll M, et al. Cobalt toxicity after McKee hip arthroplasty. J Bone Joint Surg (Br) 1975; 57-B:289–96 - PubMed